Author Question: A client with metastatic abdominal cancer has become debilitated secondary to bowel-related signs ... (Read 8 times)

jake · **on:** Jul 23, 2018

A client with metastatic abdominal cancer has become debilitated secondary to bowel-related signs and symptoms. The nurse is preparing to administer octreotide (Sandostatin). The nurse would anticipate:

1. a decrease in gastric reflux signs and symptoms.
2. a decrease in nausea and vomiting episodes.
3. severe constipation and possible ileus.
4. a decrease in the number of diarrheal stools.

Question 2

An adolescent client is prescribed nasal desmopressin for treatment of diabetes insipidus (DI). It is essential for the nurse to teach the client and family the signs and symptoms associated with:

1. acute renal failure.
2. hypoglycemic reaction.
3. liver failure.
4. water intoxication.

phuda · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 4
Rationale 1: This medication is not used to treat reflux disease.
Rationale 2: This medication does not decrease nausea and vomiting.
Rationale 3: Severe constipation is unlikely with this medication.
Rationale 4: Sandostatin is indicated for the management of signs and symptoms associated with metastatic carcinoid cancers and vasoactive intestinal peptide tumors. Severe diarrhea can result with these tumors, and Sandostatin should decrease the number of stools and increase stool consistency.
Global Rationale: Sandostatin is indicated for the management of signs and symptoms associated with metastatic carcinoid cancers and vasoactive intestinal peptide tumors. Severe diarrhea can result with these tumors, and Sandostatin should decrease the number of stools and increase stool consistency. It is not indicated to treat reflux disease or nausea and vomiting and will not result in severe constipation.

Answer to Question 2

Correct Answer: 4
Rationale 1: Desmopressin does not cause kidney failure.
Rationale 2: Desmopressin does not cause hypoglycemia.
Rationale 3: Desmopressin does not cause liver failure.
Rationale 4: Desmopressin is a synthetic form of ADH. It corrects the polydipsia and polyuria associated with DI. Water intoxication and severe hyponatremia are real concerns if the client does not decrease fluid intake as the drug takes effect. Coma and death can result if the amount of fluid in the bloodstream is not decreased.
Global Rationale: Desmopressin is a synthetic form of ADH. It corrects the polydipsia and polyuria associated with DI. Water intoxication and severe hyponatremia are real concerns if the client does not decrease fluid intake as the drug takes effect. Coma and death can result if the amount of fluid in the bloodstream is not decreased. The drug does not cause kidney failure, hypoglycemia, or liver failure.